| Originator: |
|
DHSC & NHS England and Improvement: Supply disruption alert
|
|
|
|
- Care Trusts
- Mental Health Trusts
- Specialists Trusts
- Learning Disabilities Trusts
- Mental Health & Social Care Trusts
- Ambulance Trusts
- Mental Health & Learning Disabilities Trusts
- Acute Trusts
- Community Trusts
|
|
|
- MHRA (Medicines) Drug Alerts (Various Recipients)
- Other contacts
- Independent Healthcare Providers (registered with CAS)
- Clinical Commissioning Groups
- NHS Foundation Trusts (England) - Medical Director
- NHS Foundation Trusts (England) - Chief Executive
- Special Health Authorities
- NHS Trusts (England) - Medical Director
- CMO Urgent Messages - Non-NHS Recipients on Public Health Link
- MHRA (Medicines) Drug Alerts - Non-NHS Recipients
- Territorial CMOs in Northern Ireland, Scotland & Wales
- Regional Directors of Public Health
- Consultants in Communicable Diseases
- CMO Urgent Messages - Recipients on Public Health Link
- Director of Public Health
- NHS Trusts (England) - Chief Executive
- DHSC Supply Disruption - Medicines
|
| Title: |
|
Atracurium besilate solution for injection vials and ampoules (all strengths) - Update
|
| Broadcast content: |
|
This alert provides an update to SDA 2020 014 issued on 02 December 2020.
Given the links to covid-19 we have sent this alert to a broader mailing list than would usually receive a Supply Disruption Alert of this type.
|
| Additional information: |
|
This alert is not relevant to primary care
|
| Action underway deadline: |
|
17-Dec-2020
|
| Action complete deadline: |
|
18-Dec-2020
|